Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celebrex premedication for endodontic pain
NCT03339544Unknown
- Sponsor
- Cairo University
- Start
- Dec 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of celecoxib oral solution in irreversible pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Pain intensity (intra-operative) at 2 hours. Status: unknown.
02
Drugs
celecoxib oral solution
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT03339544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339544.